Remove 2019 Remove 2022 Remove Data Remove Treatment
article thumbnail

With $20M to spend on marijuana research for veteran care, Michigan seeks proposals

Cannabis Law Report

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. 1, 2019, the day legal sales began, and Sept. The deadline for proposals is Friday, July 16. Between Dec.

article thumbnail

Dales Report: 10 Psychedelic Companies To Watch In 2022

Cannabis Law Report

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Global Psychedelics Market Is Projected to Earn $12 Billion by 2029

Veriheal

The psychedelic drugs here include LSD, MDMA, psilocybin, ketamine, and ayahuasca, which are in high demand for mental health treatment and other therapeutic reasons. As of 2022, the global psychedelics market was valued at $4.87 billion in the next six years. .” Why Is the Psychedelics Market Growing?

Therapy 109
article thumbnail

Press Release: Beckley Psytech Announces Partnership With Ksana Health, Building on Digital Strategy to Deliver Optimised Patient Outcomes

Cannabis Law Report

Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. June 14, 2022 02:00 AM Eastern Daylight Time. Dr. Nick Allen, co-founder and CEO of Ksana Health, commented: “Psychedelic treatments are offering exciting new approaches to recovery from mental disorders.

article thumbnail

Legal Framework for the Use of Psychedelics in Switzerland

Cannabis Law Report

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 billion by 2029.

article thumbnail

Oregon Cannabis: State of the State (2023)

Canna Law Blog

Sales fell (again) along with licensee numbers (for the first time) According to OLCC data , retail sales between January 1, 2023 and November 30, 2023 clocked in at $874 million. decrease from $994 million in 2022, which itself was the first calendar year cannabis sales contracted in Oregon. That tally would be a 4.1%

Hemp 86
article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8]